Kymera Therapeutics, Inc. - Common Stock (NQ:KYMR)
Price and Volume
Detailed Quote| Volume | 34,984 |
| Open | 88.59 |
| Bid (Size) | 88.78 (100) |
| Ask (Size) | 90.00 (1,500) |
| Prev. Close | 88.43 |
| Today's Range | 87.37 - 90.00 |
| 52wk Range | 19.45 - 103.00 |
| Shares Outstanding | 55,307,775 |
| Dividend Yield | N/A |
Top News
More News
Performance
| YTD |
+23.4%
|
+23.4%
|
| 1 Month |
+26.3%
|
+26.3%
|
| 3 Month |
+36.9%
|
+36.9%
|
| 6 Month |
+114.6%
|
+114.6%
|
| 1 Year |
+154.2%
|
+154.2%
|
More News
Read More
Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks ↗
January 01, 2026
Via MarketBeat
Streaming Wars Go Hostile Just as Wall Street Braces for the Fed ↗
December 09, 2025
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
Via Benzinga
What to Expect from Kymera Therapeutics's Earnings ↗
August 08, 2025
Via Benzinga
What's going on in today's session ↗
December 08, 2025
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
December 08, 2025
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
December 08, 2025
Via Chartmill
Why Is KYMR Stock Up 30% Pre-Market Today? ↗
December 08, 2025
Via Stocktwits
Topics
Economy
These stocks are moving in today's after hours session ↗
December 05, 2025
Via Chartmill
Kymera (KYMR) Q3 2025 Earnings Call Transcript ↗
November 27, 2025
Via The Motley Fool
Topics
Earnings
10 Analysts Have This To Say About Kymera Therapeutics ↗
November 05, 2025
Via Benzinga
The Analyst Verdict: Kymera Therapeutics In The Eyes Of 6 Experts ↗
October 17, 2025
Via Benzinga
Breaking Down Kymera Therapeutics: 4 Analysts Share Their Views ↗
September 16, 2025
Via Benzinga
Kymera Revenue Drops 55 Percent in Q2 ↗
August 11, 2025
Via The Motley Fool
Topics
Intellectual Property
Via Benzinga
Earnings Scheduled For August 11, 2025 ↗
August 11, 2025
Via Benzinga
Frequently Asked Questions
Is Kymera Therapeutics, Inc. - Common Stock publicly traded?
Yes, Kymera Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Kymera Therapeutics, Inc. - Common Stock trade on?
Kymera Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Kymera Therapeutics, Inc. - Common Stock?
The ticker symbol for Kymera Therapeutics, Inc. - Common Stock is KYMR on the Nasdaq Stock Market
What is the current price of Kymera Therapeutics, Inc. - Common Stock?
The current price of Kymera Therapeutics, Inc. - Common Stock is 89.76
When was Kymera Therapeutics, Inc. - Common Stock last traded?
The last trade of Kymera Therapeutics, Inc. - Common Stock was at 02/24/26 09:48 AM ET
What is the market capitalization of Kymera Therapeutics, Inc. - Common Stock?
The market capitalization of Kymera Therapeutics, Inc. - Common Stock is 4.96B
How many shares of Kymera Therapeutics, Inc. - Common Stock are outstanding?
Kymera Therapeutics, Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>